NCATS Announces Awards for Tissue Chip for Disease Modeling and Efficacy Testing

Funding Will Support the Development of 3-D Human Tissue Models

NIH announced 13 two-year awards to develop 3-D tissue chip research platforms that model disease and test drug efficacy prior to clinical trials. Supported through NCATS’ Tissue Chip for Drug Screening program, these Tissue Chips for Disease Modeling and Efficacy Testing awards represent the first phase of a five-year initiative to help scientists better understand disease mechanisms and predict more accurately how patients will respond to specific drugs.